GLUTATHIONE BASED APPROACHES TO IMPROVING CANCER-TREATMENT

Citation
Lm. Kauvar et al., GLUTATHIONE BASED APPROACHES TO IMPROVING CANCER-TREATMENT, Chemico-biological interactions, 112, 1998, pp. 225-238
Citations number
37
Categorie Soggetti
Pharmacology & Pharmacy","Chemistry Medicinal",Toxicology,Biology,Biology,Chemistry
ISSN journal
00092797
Volume
112
Year of publication
1998
Pages
225 - 238
Database
ISI
SICI code
0009-2797(1998)112:<225:GBATIC>2.0.ZU;2-1
Abstract
The use of cytotoxic chemotherapy for cancer therapy has been very suc cessful in the treatment and often cure of patients with particular ne oplasms, such as testicular carcinomas and some lymphomas. In addition , the use of adjuvant chemotherapy in patients whose primary tumor has been surgically removed contributes significantly to cure rates in so me of the more common malignancies such as breast carcinoma and colon cancer. Nonetheless, for most patients with metastatic malignancies, c urrent antineoplastic drugs provide only brief remissions with few or no long term cures. In addition, the side effects of therapy lead to s ubstantial morbidity in nearly all patients. Insights derived from mod el system studies on two glutathione based lead compounds, TER286 and TER199, suggest new clinical strategies and raise interesting basic re search questions regarding the cell biology foundations of cancer chem otherapy. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.